Cardiovascular Disease and Psoriasis

From a western clinical perspective, psoriasis is now viewed as a systemic inflammatory disease with important cardiovascular implications. Population studies and meta-analyses consistently demonstrate higher rates of myocardial infarction, stroke, and cardiovascular mortality in psoriasis compared with the general population, with risk magnified in individuals with severe disease, earlier onset, longer duration, or concomitant psoriatic arthritis. The association persists after adjustment for traditional risk factors, supporting an independent contribution from psoriatic inflammation. Mechanistically, psoriasis is driven by immune activation along the TNF‑α/IL‑23/IL‑17 axis. These cytokines promote endothelial activation, oxidative stress, and leukocyte adhesion, fostering the initiation and progression of atherosclerotic plaques. Endothelial dysfunction and increased vascular inflammation have been demonstrated using flow-mediated dilation and FDG-PET imaging. These insights explain why cardiometabolic comorbidities—obesity, insulin resistance, dyslipidemia, and hypertension—cluster with psoriasis and cumulatively elevate absolute cardiovascular risk. Clinically, major guidelines list psoriasis as a cardiovascular risk‑enhancing factor, prompting vigilant screening for blood pressure, lipids, glucose abnormalities, tobacco use, and obesity. Management follows standard prevention frameworks: lifestyle modification (Mediterranean-style eating, physical activity, weight management, smoking cessation), statins for indicated lipid lowering, and appropriate antihypertensive and glucose-lowering therapies. The choice of psoriasis therapy may also influence cardiovascular biology. Methotrexate and TNF‑α inhibitors have been associated in observational cohorts with fewer cardiovascular events, and biologics targeting IL‑17 or IL‑23 improve endothelial function and vascular inflammation on surrogate measures. However, definitive randomized evidence for reductions in hard cardiovascular outcomes with psoriasis biologics is limited, so prevention still hinges on aggressive risk factor control. Multidisciplinary collaboration between dermatology, primary care, and cardiology can align skin and heart health goals, especially in severe or long-standing disease.

Traditional and integrative paradigms approach the psoriasis–cardiovascular connection through the lens of systemic balance. In Traditional Chinese Medicine, psoriasis is often attributed to blood heat and blood stasis; when heat dries fluids and stagnates blood, the skin becomes inflamed and plaques form, and circulation may be compromised in the vessels. Therapy aims to clear heat, move blood, and calm the spirit using tailored herbal formulas, acupuncture, and dietary guidance. In Ayurveda, psoriasis is linked to aggravated pitta and kapha with accumulation of ama (metabolic toxins), which can disturb blood and fat tissues—paralleling modern concepts of inflammation and dysmetabolism. Treatment emphasizes pitta‑pacifying diet, digestive strengthening, daily routines, herbal supports such as turmeric (curcumin), and, when appropriate, supervised detoxification (panchakarma). Across these systems, mind–body practices—yoga, meditation, breathwork—address stress reactivity that can exacerbate flares and elevate blood pressure. Integrative nutrition encourages whole, minimally processed, plant‑forward eating patterns rich in omega‑3 fats and polyphenols, which modern studies associate with improved cardiometabolic markers and, in some cases, milder psoriasis severity. Emerging research lends support to select traditional tools: small trials and reviews suggest curcumin may reduce psoriatic inflammation, and yoga-based programs can modestly lower blood pressure and improve quality of life. Safety and evidence appraisal remain important. Herbal medicines and intensive detoxification procedures require professional oversight to avoid interactions or adverse effects, particularly in people taking cardiovascular medications. Integrative clinicians often combine evidence‑based lifestyle measures with conventional therapies, using acupuncture, stress reduction, and mind–body approaches as adjuncts. In this blended model, the shared goal aligns with western practice: reduce systemic inflammation, improve circulation and metabolic health, and support sustainable habits that benefit both skin and heart.